PEG-asparaginase
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PEG-asparaginase, covering 2009-09-30 to 2020-07-07. Get the full timeline:
Most recent: Clinical Trial Update: Anti-PD-1 Antibody Combined With Peg-Asparaginase and Chidamide for the Early Stage of NK/T Cell Lymphoma [Phase 2]